PODXL and acute myeloid leukemia: Another report revealed by flow cytometry moderate levels of PODXL expression in 15 cases and high levels in 13 cases from a cohort of 73 patients with acute myeloid leukemia, and associated PODXL expression in leukemic blasts with a monocytic immunophenotype, a subtype characterized by poor clinical outcome and short survival [29].